It didn’t take long for Kennesaw State University student Lilianna Kocai to discover a passion for research. All it took was a little nudge from assistant professor Carl Saint-Louis. As a freshman in ...

Bambusa Therapeutics has raised about $90 million to build out a pipeline of next-gen bispecific antibodies targeting ...

The National Institutes of Health proposal would limit indirect costs for research projects to 15 percent of grants.

Roche Holding AG’s US unit removed diversity and inclusion targets from its website, the latest in a series of publicly traded companies to bow to US President Donald Trump’s push against equal ...

“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...

Sage Therapeutics stock gained after it announced that its board of directors has rejected the unsolicited, non-binding proposal offer from biotech giant Biogen to acquire the remaining shares of ...

Check out the latest biotech industry news, from hydrogels supporting patient-derived xenograft studies and NGS panels capable of detecting MRD, to a generative AI platform for biology and chemistry ...

President Trump’s Saturday night proposal that Palestinians vacate a devastated Gaza marked a sharp break with his predecessor and introduced a contentious new initiative into his unfolding ...

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock ...

Avec Les Echos suivez en temps réel toute l'actualité financière puisée aux meilleures sources des sociétés cotées sur les bourses de Paris, Bruxelles, Amsterdam, Lisbonne, Francfort et New York.

This reflects ongoing volatility and subdued investor sentiment in the biotech sector. Dividend Proposal ... AG based on their extensive investment research. This release contains forward-looking ...

Fourth quarter 2024: BB Biotech shares returned -2.7% in CHF and -3.5% in EUR. NAV performance for the fourth quarter was +2.7% in CHF, +2.8% in EUR and -4.3% in USD. Fourth-quarter net profit of CHF ...